16.02.2015 • NewsAir LiquideDede Willamsinvestment

Air Liquide to Build $170 Million Gases Unit for Yuhuang

Air Liquide plans to invest around $170 million in a plant to supply oxygen for Chinese petrochemical giant Yuhuang Chemical's planned methanol manufacturing complex in St. James Parish, Louisiana.

The methanol facility, set to start up in the second half of 2017, is expected to be one of the largest of its kind in the US, with a capacity of 5,500 t/d.

Air Liquide said it has signed a long-term agreement to supply Yuhuang Chemical with 2,400 t/d of oxygen. The French gases producer's air separation unit for production of oxygen, nitrogen and argon will be connected to Air Liquide's Louisiana pipeline system, as well as Yuhuang Chemical's St. James site.

The gases company also recently signed a contract to license its proprietary MegaMethanol process technology to Yuhuang Chemical.

Construction of the Yuhuang complex is slated for begin in 2016, with the first $750 million phase of the methanol project planned to start up in 2018.

When this phase is completed, the Chinese firm plans to build a second $500 million methanol plant, lifting its annual methanol capacity to 3.3 million t/y. A third phase will include a methanol derivatives plant for chemical intermediates.

The methanol complex will be the first foreign investment for Yuhuang Chemical, a subsidiary of China's Shandong Yuhuang Chemical Co.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.